Also, the diagnostic performance of the reference model of HE4, CA125 and age was higher for benign tumors vs. cancer compared to benign tumors vs. borderline + cancer, illustrative of the diagnostic limitations of discriminating benign from borderline tumors using protein biomarkers. This evidence concerns the gene MUC16 and benign neoplasm.